Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 344 participants.

Also called NCT07471282

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 344 participants (planned count) (from the registry)
Sponsor
Chuansheng Zhao (from the registry)
Registry
  • NCT NCT07471282
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07471282. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy
Acronym
RECLAIM-TNK
Condition
Stroke
Intervention (Drug)
Tenecteplase (0.0938mg/kg)
Intervention (Drug)
Placebo
Lead sponsor
Chuansheng Zhao (class: other)

Record details

Record id
cardio:ct-nct07471282
Content hash
1741bca71276cf5c3121af641e6432a2092e34637b59012fd5b48d689bf778c0